lasofoxifene shows promise for women with esr1-mutated mbc
Published 1 year ago • 132 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
4:34
lasofoxifene vs fulvestrant for locally advanced/metastatic er /her2- breast cancer: elaine trial
-
2:06
elaine 1: esr1 mutations in ctdna from er /her2- mbc treated with lasofoxifene or fulvestrant
-
4:39
serd vs investigator’s choice of endocrine monotherapy for er /her2-advanced/mbc
-
4:00
mirvetuximab soravtansine shows promise in frα-positive, platinum-sensitive ovarian cancer
-
1:10
dr. cristofanilli on data with lasofoxifene in esr1-mutant breast cancer
-
1:29
dr. cristofanilli on lasofoxifene in esr1-mutant breast cancer
-
8:05
metastatic breast cancer: estrogen receptor mutations detected are associated with worse survival
-
1:31:39
update: sermonix trials of lasofoxifene to treat metastatic breast cancer with an esr1 mutation
-
10:23
sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment o...
-
1:12
dr. graff underscores unmet needs in esr1-mutated breast cancer
-
3:24
elacestrant shows improved pfs in patients with er-positive/her2-negative metastatic breast cancer
-
4:15
lasofoxifene vs fulvestrant for hr-positive breast cancer
-
37:03
esr1 mutations in metastatic breast cancer: should i get tested?
-
30:44
what's new for the patient with er /her2- mbc progressing on cdk 4/6 inhibitor therapy? expert pe...
-
2:52
new breast cancer drug study results are promising.
-
7:08
selective oestrogen receptor degraders as treatment for er positive/her2 negative advanced/metas...
-
2:32
dr. goetz on treatment challenges for esr1-mutant breast cancer
-
1:12
dr. fuqua on esr1 mutations in primary breast cancer
-
20:05
esr1 mutation: the need for & role of testing in er / her2- advanced or metastatic breast cancer